The Oceania Times

Top Menu

  • About us
  • Contact Us
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions

Main Menu

  • Australian Economy
  • Brokers
  • Commodities
  • Currencies
  • Financial Market
  • Gold and Precious Metals
  • Investment
  • Stock Shares
  • About us
  • Contact Us
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions

logo

The Oceania Times

  • Australian Economy
  • Brokers
  • Commodities
  • Currencies
  • Financial Market
  • Gold and Precious Metals
  • Investment
  • Stock Shares
  • Truist Financial Corp. sells AXIS Capital Holdings Limited (NYSE:AXS) shares

  • Industry investment SC’s largest ever with 1,500 jobs

  • gold price: Gold likely to consolidate ahead of the US FOMC decision

  • Raymond James & Associates sells 2,165 Masonite International Co. shares (NYSE:DOOR)

  • Raymond James & Associates has purchased shares of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM).

Stock Shares
Home›Stock Shares›Stephane Arsenault Sells 1,400 Shares of Héroux-Devtek Inc. (TSE:HRX) Stock

Stephane Arsenault Sells 1,400 Shares of Héroux-Devtek Inc. (TSE:HRX) Stock

By Megan
May 30, 2022
62
0
Share:

Héroux-Devtek logoHéroux-Devtek Inc. (TSE:HRX – Get Rating) Senior Officer Stephane Arsenault sold 1,400 shares of the stock in a transaction on Friday, May 27th. The shares were sold at an average price of C$15.53, for a total transaction of C$21,742.00. Following the transaction, the insider now directly owns 40,009 shares in the company, valued at approximately C$621,339.77.

Stephane Arsenault also recently made the following trade(s):

  • On Wednesday, May 25th, Stephane Arsenault sold 2,500 shares of Héroux-Devtek stock. The stock was sold at an average price of C$15.16, for a total transaction of C$37,900.00.

TSE HRX traded up C$0.66 during trading hours on Monday, reaching C$16.31. 56,222 shares of the company’s stock traded hands, compared to its average volume of 27,674. Héroux-Devtek Inc. has a 52-week low of C$13.46 and a 52-week high of C$19.65. The firm has a market cap of C$562.48 million and a PE ratio of 18.12. The firm has a 50-day simple moving average of C$15.92 and a 200 day simple moving average of C$16.89. The company has a debt-to-equity ratio of 62.69, a current ratio of 2.31 and a quick ratio of 1.14.

Héroux-Devtek (TSE:HRX – Get Rating) last issued its quarterly earnings results on Thursday, May 19th. The company reported C$0.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of C$0.24 by C$0.14. The business had revenue of C$147.46 million for the quarter, compared to analysts’ expectations of C$146.00 million. Sell-side analysts forecast that Héroux-Devtek Inc. will post 1.2400001 EPS for the current fiscal year.

(Ad)

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

A number of equities research analysts have issued reports on HRX shares. Scotiabank cut their price target on shares of Héroux-Devtek from C$24.00 to C$21.00 in a report on Friday, May 20th. National Bankshares dropped their target price on shares of Héroux-Devtek from C$26.00 to C$25.00 and set an “outperform” rating for the company in a research report on Friday, May 20th. Raymond James reaffirmed an “outperform” rating and issued a C$20.50 target price on shares of Héroux-Devtek in a research report on Thursday, February 10th. Finally, TD Securities lifted their price target on shares of Héroux-Devtek from C$23.00 to C$24.00 and gave the company a “buy” rating in a research report on Thursday, February 10th.

Héroux-Devtek Company Profile (Get Rating)

Héroux-Devtek Inc engages in the design, development, manufacture, assembling, and repair and overhaul of aircraft landing gears, hydraulic and electromechanical flight control actuators, custom ball screws, and fracture-critical components. The company is also involved in the surface treatment of landing gear components; assembling and installation of aircraft components at customer assembly lines, as well as offers electronic enclosures, heat exchangers, cabinets, and titanium components.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should you invest $1,000 in Héroux-Devtek right now?

Before you consider Héroux-Devtek, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Héroux-Devtek wasn’t on the list.

While Héroux-Devtek currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 

Source link

TagsHéroux-Devtekinsider buying and sellinginstant alertsTSE:HRX
Previous Article

Short Interest in Invesco Optimum Yield Diversified ...

Next Article

You and Your Aircraft Broker: A Dynamic ...

0
Shares
  • 0
  • +
  • 0
  • 0
  • 0
  • 0

Megan

Related articles More from author

  • Investment

    Mount Yale Investment Advisors LLC Buys 3,266 Shares of Atlassian Co. (NASDAQ:TEAM)

    January 28, 2023
    By Megan
  • Stock Shares

    Marten Transport (NASDAQ:MRTN) Shares Gap Up on Earnings Beat

    July 19, 2022
    By Megan
  • Investment

    Short Interest in Diamond Hill Investment Group, Inc. (NASDAQ:DHIL) Grows By 29.6%

    July 3, 2022
    By Megan
  • Stock Shares

    Glaukos (NYSE:GKOS) Shares Down 10% Following Analyst Downgrade

    November 3, 2022
    By Megan
  • Investment

    PennyMac Mortgage Investment Trust (NYSE:PMT) Given Consensus Rating of “Hold” by Analysts

    December 11, 2022
    By Megan
  • Brokers

    Air Products and Chemicals, Inc. to Post Q3 2023 Earnings of $2.87 Per Share, Seaport Res Ptn Forecasts (NYSE:APD)

    September 13, 2022
    By Megan

Leave a reply Cancel reply

You may interested

  • Financial Market

    U.S. regulator warns of pump-and-dump IPOs, many from China

  • Investment

    4 Types of Investment Strategies for Beginners

  • Commodities

    United States Commodity Index Fund (NYSEARCA:USCI) Stock Price Up 1%

  • LATEST REVIEWS

  • TOP REVIEWS

Timeline

  • January 29, 2023

    Truist Financial Corp. sells AXIS Capital Holdings Limited (NYSE:AXS) shares

  • January 29, 2023

    Industry investment SC’s largest ever with 1,500 jobs

  • January 29, 2023

    gold price: Gold likely to consolidate ahead of the US FOMC decision

  • January 29, 2023

    Raymond James & Associates sells 2,165 Masonite International Co. shares (NYSE:DOOR)

  • January 29, 2023

    Raymond James & Associates has purchased shares of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM).

Best Reviews

Latest News

Stock Shares

Truist Financial Corp. sells AXIS Capital Holdings Limited (NYSE:AXS) shares

Trust Financial Corp. Disclosed to the Securities and Exchange Commission in its most recent Form 13F filing that during the third quarter, it reduced its holdings in AXIS Capital Holdings ...
  • Industry investment SC’s largest ever with 1,500 jobs

    By Megan
    January 29, 2023
  • gold price: Gold likely to consolidate ahead of the US FOMC decision

    By Megan
    January 29, 2023
  • Raymond James & Associates sells 2,165 Masonite International Co. shares (NYSE:DOOR)

    By Megan
    January 29, 2023
  • Raymond James & Associates has purchased shares of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM).

    By Megan
    January 29, 2023
  • Recent

  • Popular

  • Comments

  • Truist Financial Corp. sells AXIS Capital Holdings Limited (NYSE:AXS) shares

    By Megan
    January 29, 2023
  • Industry investment SC’s largest ever with 1,500 jobs

    By Megan
    January 29, 2023
  • gold price: Gold likely to consolidate ahead of the US FOMC decision

    By Megan
    January 29, 2023
  • Raymond James & Associates sells 2,165 Masonite International Co. shares (NYSE:DOOR)

    By Megan
    January 29, 2023
  • Truist Financial Corp. sells AXIS Capital Holdings Limited (NYSE:AXS) shares

    By Megan
    January 29, 2023
  • Australia’s economy: boom or bust?

    By Megan
    September 9, 2019
  • Australian economy suffers virus symptoms

    By Megan
    February 10, 2020
  • Australian economy likely already slowing in Q2 before Delta downturn

    By Megan
    August 30, 2021

Trending News

  • Stock Shares

    Truist Financial Corp. sells AXIS Capital Holdings Limited (NYSE:AXS) shares

    Trust Financial Corp. Disclosed to the Securities and Exchange Commission in its most recent Form 13F filing that during the third quarter, it reduced its holdings in AXIS Capital Holdings ...
  • Investment

    Industry investment SC’s largest ever with 1,500 jobs

    AP and T&D Reports COLUMBIA – Redwood Materials, a producer of anode and cathode battery components for electric vehicles, announced in December plans to establish operations near Ridgeville in Berkeley ...
  • Gold and Precious Metals

    gold price: Gold likely to consolidate ahead of the US FOMC decision

    Spot gold closed with a gain of nearly 0.1% in the week ending January 27. With US Q4 advance GDP, durable goods orders, weekly jobless claims, pending home sales, and ...
  • Stock Shares

    Raymond James & Associates sells 2,165 Masonite International Co. shares (NYSE:DOOR)

    The most recent report that Raymond James & Associates submitted to the Securities and Exchange Commission indicates that the investment firm liquidated a portion of its holdings in Masonite International ...
  • Stock Shares

    Raymond James & Associates has purchased shares of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM).

    Raymond James & Associates disclosed in its most recent 13F filing with the Securities and Exchange Commission that it increased its holdings in N.G.M. Biopharmaceuticals, Inc. (NASDAQ: N.G.M.) during the ...
  • About us
  • Contact Us
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
© Copyright The Oceania Times. All rights reserved.

SUBSCRIBE TO OUR NEWSLETTER

Get our latest downloads and information first. Complete the form below to subscribe to our weekly newsletter.